Monsanto has approached the U.S. Supreme Court seeking intervention in a pivotal aspect of the ongoing Roundup litigation. This development marks a significant step in the legal proceedings surrounding the controversial herbicide. Monsanto’s efforts for a Supreme Court review underscore the high stakes associated with the litigation, which has seen various legal battles over the allegations that the weed killer causes cancer.
Simultaneously, attention is drawn to the legal hurdles in the opioid crisis litigation. The judge managing the opioid multidistrict litigation is currently facing a motion for recusal, adding another layer of complexity to the ongoing legal proceedings against pharmaceutical companies implicated in the opioid epidemic.
For further details, refer to the briefing on Law.com’s Critical Mass with Aleeza Furman, which provides additional insights into these legal issues.